Literature DB >> 19726524

The heptad repeat 2 domain is a major determinant for enhanced human immunodeficiency virus type 1 (HIV-1) fusion and pathogenicity of a highly pathogenic HIV-1 Env.

Vijay Sivaraman1, Liguo Zhang, Eric G Meissner, Jerry L Jeffrey, Lishan Su.   

Abstract

Human immunodeficiency virus type 1 (HIV-1)-mediated depletion of CD4+ lymphocytes in an infected individual is the hallmark of progression to AIDS. However, the mechanism for this depletion remains unclear. To identify mechanisms of HIV-1-mediated CD4 T-cell death, two similar viral isolates obtained from a rapid progressor patient with significantly different pathogenic phenotypes were studied. One isolate (R3A) demonstrates enhanced pathogenesis in both in vivo models and relevant ex vivo lymphoid organ model systems compared to another isolate, R3B. The pathogenic determinants were previously mapped to the V5-gp41 envelope region, correlating functionally with enhanced fusion activity and elevated CXCR4 binding affinity. To further elucidate specific differences between R3A and R3B within the V5-gp41 domains that enhance CD4 depletion, R3A-R3B chimeras to study the V5-gp41 region were developed. Our data demonstrate that six residues in the ectodomain of R3A provide the major determinant for both enhanced Env-cell fusion and pathogenicity. Furthermore, three amino acid differences in the heptad repeat 2 (HR-2) domain of R3A determined its fusion activity and significantly elevated its pathogenic activity. The chimeric viruses with enhanced fusion activity, but not elevated CXCR4 affinity, correlated with high pathogenicity in the thymus organ. We conclude that the functional domain of a highly pathogenic HIV-1 Env is determined by mutations in the HR-2 region that contribute to enhanced fusion and CD4 T-cell depletion.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19726524      PMCID: PMC2772666          DOI: 10.1128/JVI.00649-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  40 in total

1.  Association of chemokine-mediated block to HIV entry with coreceptor internalization.

Authors:  Stephanie M Brandt; Roberto Mariani; Anne U Holland; Thomas J Hope; Nathaniel R Landau
Journal:  J Biol Chem       Date:  2002-01-08       Impact factor: 5.157

Review 2.  Some recent results on HIV pathogenesis with implications for therapy and vaccines.

Authors:  R C Gallo; A Garzino-Demo
Journal:  Cell Mol Biol (Noisy-le-grand)       Date:  2001-11       Impact factor: 1.770

3.  HIV envelope induces virus expression from resting CD4+ T cells isolated from HIV-infected individuals in the absence of markers of cellular activation or apoptosis.

Authors:  Audrey L Kinter; Craig A Umscheid; James Arthos; Claudia Cicala; Yin Lin; Robert Jackson; Eileen Donoghue; Linda Ehler; Joseph Adelsberger; Ronald L Rabin; Anthony S Fauci
Journal:  J Immunol       Date:  2003-03-01       Impact factor: 5.422

Review 4.  Understanding the basis of CD4(+) T-cell depletion in macaques infected by a simian-human immunodeficiency virus.

Authors:  Bijan Etemad-Moghadam; Daniela Rhone; Tavis Steenbeke; Ying Sun; Judith Manola; Rebecca Gelman; John W Fanton; Paul Racz; Klara Tenner-Racz; Michael K Axthelm; Norman L Letvin; Joseph Sodroski
Journal:  Vaccine       Date:  2002-05-06       Impact factor: 3.641

5.  Human immunodeficiency virus type 1 IIIB selected for replication in vivo exhibits increased envelope glycoproteins in virions without alteration in coreceptor usage: separation of in vivo replication from macrophage tropism.

Authors:  E D Miller; K M Duus; M Townsend; Y Yi; R Collman; M Reitz; L Su
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

Review 6.  Molecular biology of human immunodeficiency virus type 1.

Authors:  W K Wang; M Y Chen; C Y Chuang; K T Jeang; L M Huang
Journal:  J Microbiol Immunol Infect       Date:  2000-09       Impact factor: 4.399

Review 7.  Peptide and non-peptide HIV fusion inhibitors.

Authors:  Shibo Jiang; Qian Zhao; Asim K Debnath
Journal:  Curr Pharm Des       Date:  2002       Impact factor: 3.116

8.  A genetic approach to inactivating chemokine receptors using a modified viral protein.

Authors:  V McNeil Coffield; Qi Jiang; Lishan Su
Journal:  Nat Biotechnol       Date:  2003-10-12       Impact factor: 54.908

Review 9.  Role of HIV Gp41 mediated fusion/hemifusion in bystander apoptosis.

Authors:  H Garg; R Blumenthal
Journal:  Cell Mol Life Sci       Date:  2008-10       Impact factor: 9.261

10.  Productive HIV infection of resting CD4+ T cells: role of lymphoid tissue microenvironment and effect of immunomodulating agents.

Authors:  Audrey Kinter; Anitha Moorthy; Robert Jackson; Anthony S Fauci
Journal:  AIDS Res Hum Retroviruses       Date:  2003-10       Impact factor: 2.205

View more
  16 in total

1.  Resistance of human immunodeficiency virus type 1 to a third-generation fusion inhibitor requires multiple mutations in gp41 and is accompanied by a dramatic loss of gp41 function.

Authors:  Dirk Eggink; Ilja Bontjer; Johannes P M Langedijk; Ben Berkhout; Rogier W Sanders
Journal:  J Virol       Date:  2011-08-10       Impact factor: 5.103

2.  Genetic Pathway of HIV-1 Resistance to Novel Fusion Inhibitors Targeting the Gp41 Pocket.

Authors:  Yang Su; Huihiui Chong; Shengwen Xiong; Yuanyuan Qiao; Zonglin Qiu; Yuxian He
Journal:  J Virol       Date:  2015-10-07       Impact factor: 5.103

3.  Short Communication: A Recombinant Variant with Increased Envelope Entry Efficiency Emerged During Early Infection of an HIV-1 Subtype C Dual Infected Rapid Progressor.

Authors:  Kerry Gordon; Shatha Omar; Andile Nofemela; Gama Bandawe; Carolyn Williamson; Zenda Woodman
Journal:  AIDS Res Hum Retroviruses       Date:  2015-05-20       Impact factor: 2.205

4.  Mechanism of HIV-1 Resistance to Short-Peptide Fusion Inhibitors Targeting the Gp41 Pocket.

Authors:  Yang Su; Huihiui Chong; Zonglin Qiu; Shengwen Xiong; Yuxian He
Journal:  J Virol       Date:  2015-03-18       Impact factor: 5.103

5.  HIV-1 Env and Nef Cooperatively Contribute to Plasmacytoid Dendritic Cell Activation via CD4-Dependent Mechanisms.

Authors:  Natalia J Reszka-Blanco; Vijay Sivaraman; Liguo Zhang; Lishan Su
Journal:  J Virol       Date:  2015-05-13       Impact factor: 5.103

6.  Viral envelope is a major determinant of enhanced fitness of a multidrug-resistant HIV-1 variant.

Authors:  Hiroshi Mohri; Nicole Prada; Martin Markowitz
Journal:  J Acquir Immune Defic Syndr       Date:  2015-04-15       Impact factor: 3.731

7.  A rationally engineered anti-HIV peptide fusion inhibitor with greatly reduced immunogenicity.

Authors:  Frances Brauer; Kerstin Schmidt; Roland C Zahn; Cornelia Richter; Heinfried H Radeke; Jörn E Schmitz; Dorothee von Laer; Lisa Egerer
Journal:  Antimicrob Agents Chemother       Date:  2012-11-12       Impact factor: 5.191

8.  Type I interferon contributes to CD4+ T cell depletion induced by infection with HIV-1 in the human thymus.

Authors:  Vijay Sivaraman; Liguo Zhang; Lishan Su
Journal:  J Virol       Date:  2011-06-22       Impact factor: 5.103

9.  Plasmacytoid dendritic cells promote HIV-1-induced group 3 innate lymphoid cell depletion.

Authors:  Zheng Zhang; Liang Cheng; Juanjuan Zhao; Guangming Li; Liguo Zhang; Weiwei Chen; Weiming Nie; Natalia J Reszka-Blanco; Fu-Sheng Wang; Lishan Su
Journal:  J Clin Invest       Date:  2015-08-24       Impact factor: 14.808

10.  Low levels of HIV-1 envelope-mediated fusion are associated with long-term survival of an infected CCR5-/- patient.

Authors:  Paul R Gorry; Fahim Ahmad; Jon Mohl; Ghalib Alkhatib
Journal:  AIDS       Date:  2018-10-23       Impact factor: 4.177

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.